Gwenn Hansen - Insider Trading & Ownership

Location
C/O Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco, CA
Summary
The estimated net worth of Gwenn Hansen is at least $1.53M dollars as of July 30, 2025. Gwenn Hansen is the Chief Scientific Officer of Nurix Therapeutics, Inc. and owns shares of Nurix Therapeutics, Inc. (NRIX) stock worth about $1.53M.
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Gwenn Hansen
All Insider Reports
All Insider Reports

Ownership of Gwenn Hansen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NRIX Nurix Therapeutics, Inc. Chief Scientific Officer $1.53M -$247K -13.9% Jul 30, 2025

Insider Transactions Reported by Gwenn Hansen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.